BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26511074)

  • 1. Coagulation activation in sickle cell trait: an exploratory study.
    Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
    Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
    Gupta S; Carmona R; Malvar J; Young G
    Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procoagulant activity in patients with sickle cell trait.
    Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
    Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
    Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation changes in individuals with sickle cell trait.
    Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Schlegel R; Williamson P
    Am J Hematol; 2002 Feb; 69(2):89-94. PubMed ID: 11835343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombophilia in sickle cell disease: the red cell connection.
    Setty BN; Rao AK; Stuart MJ
    Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.
    Setty BN; Key NS; Rao AK; Gayen-Betal S; Krishnan S; Dampier CD; Stuart MJ
    Br J Haematol; 2012 May; 157(3):370-80. PubMed ID: 22360627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide-prednisone maintenance following autologous stem cell transplant for multiple myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10.
    Kovacs MJ; Davies GA; Chapman JA; Bahlis N; Voralia M; Roy J; Kouroukis CT; Chen C; Belch A; Reece D; Zhu L; Meyer RM; Shepherd L; Stewart KA
    Br J Haematol; 2015 Feb; 168(4):511-7. PubMed ID: 25302852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm.
    Nomura F; Ihara A; Yoshitatsu M; Tamura K; Katayama A; Ihara K
    Eur J Cardiothorac Surg; 2003 Jun; 23(6):1034-8; discussion 1038-9. PubMed ID: 12829084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen delivery index in subjects with normal haemoglobin (HbAA), sickle cell trait (HbAS) and homozygous sickle cell disease (HbSS).
    Bowers AS; Pepple DJ; Reid HL
    Clin Hemorheol Microcirc; 2008; 40(4):303-9. PubMed ID: 19126993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal haematocrit in subjects with normal haemoglobin genotype (HbAA), sickle cell trait (HbAS), and homozygous sickle cell disease (HbSS).
    Bowers AS; Pepple DJ; Reid HL
    Clin Hemorheol Microcirc; 2011; 47(4):253-60. PubMed ID: 21654054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
    Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
    PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
    Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
    Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
    J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
    Gando S; Nanzaki S; Sasaki S; Kemmotsu O
    Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemostasis alterations in sickle cell syndrome].
    Higuera D; Bravo M; Guerrero B
    Invest Clin; 2014 Jun; 55(2):173-84. PubMed ID: 24974633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell trait and the risk of venous thromboembolism among blacks.
    Austin H; Key NS; Benson JM; Lally C; Dowling NF; Whitsett C; Hooper WC
    Blood; 2007 Aug; 110(3):908-12. PubMed ID: 17409269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.